CML is a disorder characterized by the clonal expansion of BM stem cells, with the characteristic t(9;22)(q34;q11) cytogenetic abnormality that results in Philadelphia chromosome and the generation of a BCR-ABL chimeric gene (18). Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.